|

Herombopag tablets Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery1
  • Liver Disease1

Other1 trial

The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.